GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: A barrier to implementation of evidence and guidance on hypnotics

British Journal of General Practice

Volumn 56, Issue 533, 2006, Pages 964-967

  Siriwardena, A Niroshan ^a   Qureshi, Zubair ^b   Gibson, Steve ^c   Collier, Sarah ^c   Latham, Martin ^c  

^a UNIVERSITY OF LINCOLN   (United Kingdom)

^b South Park Surgery   (United Kingdom)

^c West Lincolnshire Primary Care Trust   (United Kingdom)

Author keywords

Attitude; Cross sectional studies; Hypnotics and sedatives; Physicians' practice patterns; Prescriptions

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ADULT; AGED; ANXIETY; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONCENTRATION LOSS; CONFUSION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG DEPENDENCE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG PREFERENCE; DRUG SAFETY; DRUG TOLERANCE; ELDERLY CARE; EVIDENCE BASED MEDICINE; FALLING; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH BELIEF; HEALTH SURVEY; HIP FRACTURE; HUMAN; HUMAN EXPERIMENT; INSOMNIA; MALE; MEDICAL DECISION MAKING; NORMAL HUMAN; PATIENT GUIDANCE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; SLEEP TIME; SLEEP WAKING CYCLE; SOMNOLENCE; TRAFFIC ACCIDENT; WITHDRAWAL SYNDROME;

ACETAMIDES; ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; BENZODIAZEPINES; CROSS-SECTIONAL STUDIES; ENGLAND; FAMILY PRACTICE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PIPERAZINES; PRACTICE GUIDELINES; PYRIDINES; PYRIMIDINES; QUESTIONNAIRES;

EID: 33845613100     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Baker RH, Tait C, Fraser RC. Use of benzodiazepines. BMJ 1994; 309(6951): 412.
2. Dundar Y, Dodd S, Strobl J, et al. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 2004; 19(5): 305-322.
3. Dundar Y, Boland A, Strobl J, et al. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assess 2004; 8(24): 1-125.
4. Department of Health. National Service Framework for mental health: modern standards and service models. London: Department of Health, 2003.
5. National Institute for Health and Clinical Excellence. Guidance on the use of zaleplon, zolpidem and zopiclone for the short term management of insomnia. Technology Appraisal Guidance 77. London: NICE, 2004.
6. Barnas C, Fleischhacker WW, Whitworth AB, et al. Characteristics of benzodiazepine long-term users: investigation of benzodiazepine consumers among pharmacy customers. Psychopharmacology (Berl) 1991; 103: 233-239.
7. King MB, Gabe J, Williams P, Rodrigo EK. Long term use of benzodiazepines: the views of patients. Br J Gen Pract 1990; 40: 194-196.
8. Lyndon RW, Russell JD. Benzodiazepine use in a rural general practice population. Aust N Z J Psychiatry 1988; 22(3): 293-298.
9. Nolan L, O'Malley K. Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol 1988; 35(3): 225-229.
10. Bjorner T, Laerum E. Factors associated with high prescribing of benzodiazepines and minor opiates. A survey among general practitioners in Norway. Scand J Prim Health Care 2003; 21(2): 115-120.
11. Matthews K, Eagles JM, Matthews CA. The use of antidepressant drugs in general practice. A questionnaire survey. Eur J Clin Pharmacol 1993; 45: 205-210.
12. Hamilton IJ, Reay LM, Sullivan FM. A survey of general practitioners' attitudes to benzodiazepine overprescribing. Health Bull (Edinb)1990; 48: 299-303.
13. Mah L, Upshur RE. Long term benzodiazepine use for insomnia in patients over the age of 60: discordance of patient and physician perceptions. BMC Fam Pract 2002; 3: 9.
14. Iliffe S, Curran HV, Collins R, et al. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health 2004; 8(3): 242-248.
15. Siriwardena AN. Clinical guidelines in primary care: a survey of general practitioners' attitudes and behaviour. Br J Gen Pract 1995; 45: 643-647.
16. Rawlins MD. 5 NICE years. Lancet 2005; 365: 904-908.
17. Sheldon TA, Cullum N, Dawson D, et al. What's the evidence that NICE guidance has been implemented? Results: from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ 2004; 329: 999.
18. Wathen B, Dean T. An evaluation of the impact of NICE guidance on GP prescribing. Br J Gen Pract 2004; 54: 103-107.
19. Roughead EE, Harvey KJ, Gilbert AL. Commercial detailing techniques used by pharmaceutical representatives to influence prescribing. Aust N Z J Med 1998; 28(3): 306-310.
20. Carney SL, Nair KR, Sales MA, Walsh J. Pharmaceutical industry-sponsored meetings: good value or just a free meal? Intern Med J 2001; 31(8): 446-447.
21. Lexchin J. What information do physicians receive from pharmaceutical representatives? Can Fam Physician 1997; 43: 941-945.
22. Waldron I. Increased prescribing of Valium, Librium, and other drugs - an example of the influence of economic and social factors on the practice of medicine. Int J Health Serv 1977; 7(1): 37-62.
23. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283(3): 373-380.
24. Tracy CS, Dantas GC, Upshur RE. Evidence-based medicine in primary care: qualitative study of family physicians. BMC Fam Pract 2003; 4: 6.
25. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. CMAJ 1995; 153(5): 553-559.
26. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ 1993; 149: 1401-1407.
27. Gibbons RV, Landry FJ, Blouch DL, et al. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med 1998; 13: 151-154.
28. Rogers EM. Diffusion of innovations. New York, London: Free Press, 1995: 1-38.